Applications of Genome Editing Technologies in CAD Research and Therapy with a Focus on Atherosclerosis-Reference-Cited by-同舟云学术

Applications of Genome Editing Technologies in CAD Research and Therapy with a Focus on Atherosclerosis

Published:2023-09-13 Issue:18 Volume:24 Page:14057
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Mak Michelle C. E.¹^ORCID,Gurung Rijan¹^ORCID,Foo Roger S. Y.¹

Affiliation:

1. Cardiovascular Research Institute, Cardiovascular and Metabolic Disease Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, 14 Medical Drive, MD6, #08-01, Singapore 117599, Singapore

Abstract

Cardiovascular diseases, particularly coronary artery disease (CAD), remain the leading cause of death worldwide in recent years, with myocardial infarction (MI) being the most common form of CAD. Atherosclerosis has been highlighted as one of the drivers of CAD, and much research has been carried out to understand and treat this disease. However, there remains much to be better understood and developed in treating this disease. Genome editing technologies have been widely used to establish models of disease as well as to treat various genetic disorders at their root. In this review, we aim to highlight the various ways genome editing technologies can be applied to establish models of atherosclerosis, as well as their therapeutic roles in both atherosclerosis and the clinical implications of CAD.

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

https://www.mdpi.com/1422-0067/24/18/14057/pdf

Reference153 articles.

1. GBD 2019 Diseases and Injuries Collaborators (2020). Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet, 396, 1204–1222.

2. (2023, July 18). Cardiovascular Diseases (CVDs). Available online: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).

3. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study;Roth;J. Am. Coll. Cardiol.,2020

4. Epidemiology and Aetiology of Heart Failure;Ziaeian;Nat. Rev. Cardiol.,2016

5. Significance of Ischemic Heart Disease in Patients with Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study;Vedin;Circ. Heart Fail.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Landscape of Gene Therapy for the Treatment of Cardiovascular Disorders;Current Gene Therapy;2024-10

2. Established and Emerging Nucleic Acid Therapies for Familial Hypercholesterolemia;Circulation;2024-08-27

3. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy;Journal of Controlled Release;2024-08

4. The Significance of Genetically Determined Methylation and Folate Metabolism Disorders in the Pathogenesis of Coronary Artery Disease: A Target for New Therapies?;International Journal of Molecular Sciences;2024-06-25

5. Early-Onset or Premature Coronary Artery Disease;Current Medicinal Chemistry;2024-06-04